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bstract
The effects of ethylacetate extract of red onion (Allium  cepa) tunic (ACTE) on some hemodynamic and biochemical parameters were evaluated
n normotensive albino rats. Blood pressure parameters were determined in anaesthetized rats orally administered ACTE (10-, 20-, or 40 mg/kg)
r ramipril (1 mg/kg) once daily for 14 days. Respectively, 10-, 20-, or 40 mg/kg ACTE produced significant (P  < 0.01), dose-dependent fall in
ystolic blood pressure, SBP (21%, 27%, 33%), diastolic blood pressure, DBP (6%, 10%, 16%), pulse pressure, PP (42%, 49%, 56%), mean arterial
lood pressure, MAPB (13%, 18%, 23%) and heart rate, HR (4%, 5%, 7%). The highest effective dose (40 mg/kg) compared well with ramipril
1 mg/kg) with regards to SBP (41%), DBP (19%), PP (70%), MABP (29%) and HR (10%). Similar trends (decreases) were recorded for 40 mg/kg
CTE and ramipril, respectively, as regards the activities of serum enzymes: creatine kinase (60% and 65%), ALT (18% and 14%) and ALP (28%
nd 16%). HPLC fingerprints of the flavonoid-rich ACTE revealed that flavonols: quercetin, quercitrin, isoquercitrin, rutin and kaempferol are the
ctive flavonoids. The results demonstrate the hypotensive effect of A.  cepa  tunic flavonoids initiating further investigation of their individual or
ynergistic contribution(s) to the observed effects.
 2015 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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a.  Introduction
Agents with hypotensive effect could be of therapeutic sig-
ificance in the advent of clinical or experimental-induced
ypertension. One quarter of the world’s adult population is
fflicted by hypertension, and this is likely to increase to 29%
y 2025 [1]. The common progressive disorder leads to several∗ Corresponding author: Department of Biochemistry, Federal University
ye-Ekiti, PMB 373, Oye-Ekiti, Nigeria. Tel.: +234 8060162922.
E-mail address: komokay93@yahoo.com (K. Komolafe).
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213-4530/© 2015 Beijing Academy of Food Sciences. Production and hosting by Ehronic diseases such as cardiovascular disease, stroke, renal
isease and diabetes [2].
Plants constitute a rich and diverse source of secondary
etabolites that have long contributed to the development of
mall-molecule based therapeutics [3]. Onion (Allium  cepa  L.),
 bulbous herb belonging to the family Alliceae, is a widely
onsumed vegetable. It is a good source of dietary phytochemi-
als including organosulphur compounds and flavonoids [4]. As
 result of their phytoconstituents, onions exhibit considerable
ntioxidant properties and could modulate the detoxification
ystems [5]. Thus, onion intake is reported to have several
eneficial effects on health, such as preventing tumors and
ancers [6], cardiovascular diseases [7] and hypertension
8]. Most of the documented beneficial effects of onions,
lsevier B.V. All rights reserved.
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ncluding inhibition of platelet aggregation [9], hypoglycaemic,
ypolipidemic and antiatherosclerotic [10,11], and antioxidant
nd antiapoptotic effects [12], have centered on the bulb or other
dible parts rather than the tunic which is normally discarded
s wastes. We envisaged that this underutilized part of onion,
hich has not received much attention all the while, may have
otential benefits to human health. To the best of our knowledge,
here is a dearth of information on effect of red onion (A.  cepa)
unic on hemodynamic parameters. This work was therefore
nitiated to provide scientific information in this regard.
.  Materials  and  methods
.1.  Chemicals
Glutathione, 5′,5′-dithiobis-(2-nitrobenzoate) DTNB,
pinephrine and hydrogen peroxide were purchased from
igma Chem., Co. (London, UK). Alanine aminotransferase
ALT), aspartate aminotransferase (AST), lactate dehydro-
enase (LDH), creatine kinase (CK), total protein and total
holesterol kits were obtained from Randox Laboratories, UK.
ll other chemicals were of analytical grade and were either
btained from Sigma–Aldrich or British Drug Houses, (Poole,
K).
.2.  Plant  material
Red onions (A.  cepa) were bought from Shasha market, out-
kirt Akure metropolis, Nigeria, in the month of February 2013.
otanical identification and authentication were carried out at
he herbarium of the Forestry Research Institute of Nigeria
FRIN), Ibadan, Nigeria.
.3.  Preparation  of  ethylacetate  extract  of  red  onions  (A.
epa) tunic
The tunics of onions were removed, cleaned, air-dried and
ulverized. The powdered sample (80 g) was macerated in
00 mL of ethyl acetate (Sigma Chemicals; USA) for 4 h at
0 ◦C, with constant agitation. The mixture of the solvent and the
round sample was filtered first with mesh cloth, and then with
lter paper (Whatman No. 1) and concentrated using a rotary
vaporator. The residue was kept in a refrigerator at 4 ◦C until
urther uses. Prior to the experiments, the ethylacetate extract
as dissolved in distilled water and diluted to the desired con-
entrations to give a water-soluble fraction (ACTE).
.4.  Phytochemical  screening
ACTE was screened for the presence of alkaloids, saponins,
annins, steroids, anthraquinones, terpenoids, flavonoids and
hlobatannins as described in our previous work [13]..5.  Determination  of  total  ﬂavonoid  content
The colorimetric method described by Dewanto et al. [14]
as employed in the quantification of total flavonoids in ACTE.
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o 250 L of the suitably diluted sample, 75 L of 5% NaNO2
olution, 150 L of freshly prepared 10% AlCl3 solution, and
00 L of 1 mol/L NaOH solution were added. The final volume
as adjusted to 2.5 mL with deionized water and the mixture left
o stand for 5 min. The absorption was thereafter measured at
10 nm against the same mixture, without the sample, as blank.
he amount of total flavonoids was expressed as quercetin equiv-
lents (QE, mg quercetin/g sample) through the calibration curve
f quercetin.
.6.  Quantiﬁcation  of  ﬂavonoids
Reverse phase chromatographic analyses were carried out
nder gradient conditions using C18 column (4.6 mm ×  150 mm)
acked with 5 m diameter particles; the mobile phase was water
ontaining 2% acetic acid (A) and methanol (B), and the compo-
ition gradient was: 5% of B until 2 min and changed to obtain
5%, 40%, 50%, 60%, 70% and 100% B at 10 min, 20 min,
0 min, 40 min, 50 min and 60 min, respectively, following the
ethod described by Peroza et al. [15] with slight modifica-
ions. ACTE was analyzed at a concentration of 12 mg/mL.
he presence of flavonoids was investigated, namely, quercetin,
soquercitrin, quercitrin, rutin and kaempferol. Identification of
hese compounds was performed by comparing their retention
ime and UV absorption spectra with those of commercially
vailable standards and by DAD spectra (300–600 nm). The flow
ate was 0.7 mL/min, injection volume 50 L and the wave-
ength was 356 nm. The samples and mobile phase were filtered
hrough 0.45 m membrane filter (Millipore) and then degassed
y ultrasonic bath prior to use. Stock solutions of standards
eferences were prepared in the HPLC mobile phase at a concen-
ration range of 0.050–0.500 mg/mL for quercetin, isoquercitrin,
uercitrin, kaempferol and rutin. All chromatography operations
ere carried out at ambient temperature and in triplicate.
The limit of detection (LOD) and limit of quantification
LOQ) were calculated based on the standard deviation of
he responses and the slope using three independent analytical
urves, as defined by Sabir et al. [16]. LOD and LOQ were cal-
ulated as 3.3 and 10 σ/S, respectively, where σ  is the standard
eviation of the response and S is the slope of the calibration
urve.
.7.  Animals
Adult male rats (Wistar strain) weighing 200–220 g, obtained
rom a private breeder and housed in the primate colony of
he Department of Physiology, College of Medicine, Univer-
ity of Lagos, Nigeria were used for this study. The animals
ere kept in wire mesh cages under controlled light cycle (12 h
ight/12 h dark), fed with commercial rat chow (Vital Feeds
igeria Limited) ad libitum, and liberally supplied with water.
ll animal experiments were conducted according to the guide-
ines of National Institute of Health (NIH publication 85-23,
985) for laboratory animal care and use.
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.8.  Experimental  design
Age-matched male rats were divided into five groups (n  = 5)
nd treated as follows:
Group  I:  control, distilled water (1 mL/kg).
Group II:  1 mg/kg ramipril.
Group  III:  10 mg/kg ACTE.
Group  IV:  20 mg/kg ACTE.
Group  V: 40 mg/kg ACTE.
Drugs or distilled water were administered by gavage to nor-
otensive rats once daily for 14 consecutive days. Twenty-four
ours after the last administration, animals were anaesthetized
ith a mixture of urethane (25%) and alpha-chloralose (1%) to
etermine the hemodynamic parameters. Animals were there-
fter sacrificed, blood was collected through cardiac puncture
nd hearts were excised. Sera and heart homogenates were then
repared for biochemical evaluations.
.9.  Determination  of  blood  pressure
Blood pressure parameters of rats were determined as previ-
usly described [17]. At state of anaesthesia, the animal were
aid supine and carotid artery exposed and cannulated with a
mall polyethylene catheter connected to a pressure transducer
Becton Dickinson, Sandy, UT, USA) which in turn was con-
ected to a polygraph 7D model of Grass Polygraph (Grass
nstrument Company, Quincy, Massachusetts, USA). The speed
f the equipment was 10 mm/s. The blood pressure was then
alculated as recorded in form of tracing by the polygraph
fter a 20-min stabilization period. The body temperature of
ats was maintained at 37 ◦C with a heating pad throughout
he experiment. On the tracing, the values from the baseline to
he lowest border of the tracing represent the diastolic pressure
hile from the baseline to the upper border represent the systolic
ressure. Each centimeter (cm) change on the tracing paper cor-
esponds to 20 mm Hg pressure change in the grass polygraph.
he mean arterial blood pressure (MAPB) was calculated as fol-
ows: MAPB = DP + 1/3 (SP-DP), where DP = diastolic pressure
nd SP = systolic pressure. Heart rate (beats/min) corresponds to
he number of strokes within a distance of 600 mm (60 cm) on
he polygraph recordings.
.10.  Preparation  of  serum  and  tissue  homogenate
The collected blood was allowed to clot and serum
as obtained after centrifugation at 3000 r per minute for
5 min. To prepare the tissue homogenate, excised hearts were
insed in 1.15% KCl and homogenized in aqueous Tris–HCl
uffer (50 mmol/L, pH 7.4). Homogenates were centrifuged at
000 ×  g for 20 min at 4 ◦C to obtain the supernatant fractions
hich were used for analyses.
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.11.  Measurement  of  serum  parameters
The activities of alanine aminotransferase (ALT), aspartate
minotransferase (AST), alkaline phosphatase (ALP), creatine
inase and total cholesterol concentration were estimated in
he serum using assay kits from Randox Laboratories Ltd., UK
ccording to the instructions of the manufacturer.
.12.  Assessment  of  antioxidant  status
Antioxidant status was determined in the heart homogenates
y quantifying the enzymic (superoxide dismutase and catalase)
nd non-enzymic (reduced glutathione) antioxidants.
.12.1. Determination  of  superoxide  dismutase  (SOD)
ctivity
The activity profile of SOD in the homogenates was deter-
ined by the method of Misra and Fridovich [18]. Briefly, an
liquot of the diluted sample was added to 2.5 mL of 0.05 mol/L
arbonate buffer (pH 10.2) to equilibrate in the spectropho-
ometer. The reaction was started by the addition of 0.3 mL of
reshly prepared 0.3 mmol/L adrenaline to the mixture which
as quickly mixed by inversion. The reference cuvette con-
ained 2.5 mL of buffer, 0.3 mL of substrate (adrenaline) and
.2 mL of water. The increase in absorbance at 480 nm was mon-
tored every 30 s for 150 s. A unit of SOD activity was given as
he amount of SOD necessary to cause 50% inhibition of the
xidation of adrenaline to adrenochrome during 1 min.
.12.2. Determination  of  catalase  activity
Catalase activity was determined by following the decom-
osition of H2O2 according to the method of Sinha [19]. An
liquot (1 mL) of properly diluted enzyme preparation was
apidly mixed with an assay mixture containing 4 mL of H2O2
800 mol) solution and 5 mL of 0.1 mol/L phosphate buffer
pH 7.0) in a conical flask by a gentle swirling motion. The
eaction was run at room temperature. A 1 mL portion of the
eaction mixture was withdrawn and blown into 2 mL dichro-
ate/acetic acid reagent at 60 s intervals. The H2O2 content of
he withdrawn sample was determined by taking the absorbance
t 570 nm. Catalase activity was expressed as mol H2O2 con-
umed/min/mg protein.
.12.3.  Estimation  of  reduced  glutathione  (GSH)  level
Reduced glutathione (GSH) level was assayed by measur-
ng the rate of formation of chromophoric product in a reaction
etween 5,5-dinitrobis-2-nitrobenzoic acid and free sulphydryl
roups (such as GSH) as described by Beutler et al. [20]. Tis-
ue supernatant (1 mL) was precipitated with 5% sulphosalicylic
cid (1.5 mL) by gentle mixing and allowed to stand for 5 min
efore filtering. Thereafter, 0.5 mL of filtrate was added to 2 mL
f 0.1 mol/L phosphate buffer (pH 7.4) followed by Ellman’s
eagent (0.25 mL). A blank was prepared with 2 mL of buffer,
.5 mL of diluted precipitating solution (three parts to two parts
f distilled water) and 0.25 mL of Ellman’s reagent. The optical
ensity was measured at 412 nm. GSH was proportional to the
118 O.S. Olayeriju et al. / Food Science and Human Wellness 4 (2015) 115–122
Table 1
Phytochemical constituents of ethylacetate extract of Allium cepa tunic (ACTE).
Phytochemicals Results Concentration
Flavonoids + 425.6 ± 5.92 mg QE/g extract
Tannins − –
Saponins − –
Phlobatannins − –
Anthraquinones − –
Alkaloids − –
Steroids − –
Terpenoids − –
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Table 2
Flavonoid composition of ethylacetate extract of Allium cepa tunic (ACTE).
Compounds ACTE LOD LOQ
mg/g % g/mL g/mL
Rutin 94.31 ± 0.02 9.53 0.008 0.027
Isoquercitrin 120.68 ± 0.03 12.06 0.019 0.062
Quercitrin 51.27 ± 0.01 5.12 0.023 0.075
Quercetin 78.54 ± 0.03 7.85 0.035 0.115
Kaempferol 20.93 ± 0.01 2.09 0.011 0.036
Results are expressed as mean ± standard deviations (SD) of three determina-
tions.
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aey: +: present; −: absent.
E: quercetin equivalent.
bsorbance at that wavelength and the estimate was obtained
rom a GSH standard curve.
.13.  Protein  estimation
Protein concentration was determined by the method
escribed by Lowry et al. [21] using bovine serum albumin
BSA) as standard.
.14.  Statistical  analysis
All values are expressed as mean ±  SD of five animals. Sta-
istical evaluation was done using One Way Analysis of Variance
ANOVA) followed by Duncan Multiple Range Test. The sig-
ificance level was set at P  < 0.05.
.  Results
.1.  Phytochemical  constituents  of  ACTE
The phytochemical analysis of ACTE gave positive result
o flavonoids (425.6 ±  5.92 mg quercetin equivalent/g extract)
nly, thus indicating the antioxidant phytochemicals are the
ajor constituent of the extract (Table 1).
HPLC fingerprints of the flavonoids in ACTE revealed that
utin (tR = 34.79 min; peak 1), isoquercitrin (tR = 39.13 min;
ig. 1. Representative high performance liquid chromatography profile of
avonoids in ethylacetate extract of Allium cepa tunic. Rutin (peak 1), iso-
uercitrin (peak 2), quercitrin (peak 3), quercetin (peak 4) and kaempferol (peak
).
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cOD: limit of detection; LOQ: limit of quantification.
eak 2), quercitrin (tR = 45.13 min; peak 3), quercetin
tR = 50.09 min; peak 4) and kaempferol (tR = 52.68 min; peak
) (Fig. 1), are the active flavonoids. As shown in Table 2,
he concentrations (mg/g) of the flavonols are as follows:
utin (94.31 ±  0.02), isoquercitrin (120.68 ±  0.03), quercitrin
51.27 ±  0.03), quercetin (78.54 ±  0.03) and kaempferol
20.93 ±  0.01).
.2.  Effect  on  blood  pressure  parameters
The effect of ACTE on the hemodynamic parameters of
ats treated with the extract for 14 days is depicted in
able 3. The hypotensive effect of the extract was significant
P < 0.01/P  < 0.001) and dose dependent in experimental ani-
als. Respectively, 10-, 20-, and 40 mg/kg caused significant
P < 0.05) decreases (%) in systolic blood pressure, SBP (21,
7, 33), diastolic blood pressure, DBP (6, 10, 16), pulse pres-
ure, PP (42, 49, 56), mean arterial blood pressure, MABP (13,
8, 23) and heart rate, HR (4, 5, 7) when compared with the con-
rol. The results suggest that the highest efficacy was recorded
or 40 mg/kg ACTE, which compares well with the reference
rug, ramipril, on SBP (41), DBP (19), PP (70), MABP (29)
nd HR (10).
.3.  Inﬂuence  on  serum  biochemical  indices
The effect of ACTE on serum biochemical indices of nor-
otensive rats is depicted in Table 4. Significant decrease
P < 0.001) in the activity of serum cardiac marker, crea-
ine kinase, was noticeable in experimental rats administered
0- (52%), 20- (58%) and 40 mg/kg (60%) of ACTE or
 mg/kg ramipril (65%). Serum activity of alanine aminotrans-
erase (ALT) was decreased by treatment with 10-, 20 mg/kg
CTE (P < 0.01), 40 mg/kg ACTE (P  < 0.001) and 1 mg/kg
am (P  < 0.001). Similarly, serum activity of aspartate amino-
ransferase (AST) was decreased by 40 mg/kg (P  < 0.01) and
 mg/kg Ram (P  < 0.001). Significant (P  < 0.001) lowering of
lkaline phosphatase (ALP) activity was observed in rats admin-
stered all dosages of ACTE and 1 mg/kg Ram. It could also be
bserved that 40 mg/kg ACTE produced the highest decreases
n the activities of serum ALT (18%) and ALP (28%). Con-
urrently, serum total cholesterol concentration was reduced
O.S. Olayeriju et al. / Food Science and Human Wellness 4 (2015) 115–122 119
Table 3
Effects of ethylacetate extract of Allium cepa tunic (ACTE) on blood pressure parameters of rats.
Treatment SBP (mm Hg) DBP (mm Hg) PP (mm Hg) MABP (mm Hg) HR (beats/min)
Control 67.60 ± 1.8 38.80 ± 1.3 28.80 ± 1.3 48.40 ± 1.4 399.40 ± 15.3
ACTE (10 mg/kg) 53.40 ± 1.1*** 36.80 ± 0.8** 16.60 ± 1.3*** 42.33 ± 0.7*** 382.80 ± 12.2***
ACTE (20 mg/kg) 49.60 ± 0.9*** 34.80 ± 0.8*** 14.80 ± 0.4*** 39.73 ± 0.8*** 377.80 ± 12.4***
ACTE (40 mg/kg) 45.60 ± 1.1*** 32.80 ± 0.8*** 12.80 ± 1.1*** 37.10 ± 0.8*** 369.60 ± 16.2***
Ram (1 mg/kg) 40.20 ± 1.6*** 31.60 ± 1.1*** 8.60 ± 0.9*** 34.47 ± 1.3*** 358.80 ± 13.8***
Values are expressed as mean ± standard deviation (n = 5). Ram: ramipril; SBP: systolic blood pressure; DBP: diastolic blood pressure; PP: pulse pressure; MABP:
mean arterial blood pressure; HR: heart rate.
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*** P < 0.01 compared with the normal control group.
** P < 0.001 compared with the normal control group.
y ACTE (10 mg/kg; P  < 0.01 and 20 mg/kg; P  < 0.001) and
amipril (1 mg/kg; P  < 0.001).
.4.  Effect  on  cardiac  antioxidant  status
Cardiac activities of superoxide dismutase and catalase were
espectively increased (P  < 0.001) in rats treated with 10 mg/kg
53% and 56%), 20 mg/kg (83% and 150%) and 40 mg/kg (111%
nd 197%) dosages of extract. Treatment with 1 mg/kg Ram
lso resulted in similar effects on cardiac activities of antioxi-
ant enzymes. On the contrary, the level of GSH was reduced
n experimental animals treated with all dosages of extract or
amipril (Fig. 2).
.  Discussion
The result of phytochemical screening revealed the over-
helming presence of flavonoids in the ethylacetate extract of
. cepa  tunic (ACTE). The finding is in agreement with previous
orks [22,23] which showed that ethylacetate fractions contain
igh amount of phenolics/flavoniods, thus initiating their uses
s flavonoid-rich sources. Flavonoids have aroused considerable
nterest recently because of their potential beneficial effects on
uman health. In line with previous findings on onions [5,24],
PLC screening of flavonoids in ACTE revealed the flavonols:
aempferol, quercetin and quercetin glycosides (isoquercitrin,
uercitrin and rutin) as the active flavonoids.
In the present study, we observed marked decreases in the sys-
olic and diastolic pressure, mean arterial blood pressure, pulse
ate and heart rate of rats administered ACTE. The hypotensive
o
s
t
able 4
ffects of ethylacetate extract of Allium cepa tunic (ACTE) on serum biochemical in
reatment CK (IU/L) ALT (U/L) 
ontrol 42.92 ± 4.7 8.48 ± 0.46 
CTE (10 mg/kg) 20.64 ± 2.9*** 7.88 ± 0.18**
CTE (20 mg/kg) 18.16 ± 2.3*** 7.80 ± 0.14**
CTE (40 mg/kg) 17.33 ± 1.8*** 6.96 ± 0.18***
am (1 mg/kg) 14.86 ± 2.3*** 7.32 ± 0.18***
alues are expressed as mean ± standard deviation (n = 5). Ram: ramipril; CK: creat
LP: alkaline phosphatase; CHOL: cholesterol.
** P < 0.01 compared with the normal control group.
** P < 0.001 compared with the normal control group.ffect of ACTE could be of therapeutic benefit in the event of
linical or drug-induced elevated blood pressure or hyperten-
ion [25] where reduction in blood pressure is highly desirable.
he result was comparable to that recorded for the popular
ngiotensin-converting enzyme (ACE) inhibitor and hypoten-
ive drug, ramipril. It might be impossible to categorically
scertain the mechanism underlying the hypotensive effect of
CTE from the data obtained in this study. It is however known
hat ACE inhibitors such as ramipril and catopril lower blood
ressure and bring about fewer cardiovascular events in high
isk populations by binding a zinc molecule at the active site
f ACE, thereby slowing down the conversion of angiotensin I
o the potent vasoconstrictor, angiotensin II [26]. Quercetin and
ts glycosides are often the most abundant polyphenolic com-
ounds found in the human diet, and richly found in the peel of
nions [4,5,24]. Several beneficial cardiovascular effects have
een ascribed to this phytochemical, including antihyperten-
ive effect and ability to improve endothelial function [27,28].
lavonoids are known to bind metal ions, such as zinc, and
here is evidence that quercetin may inhibit ACE activity via
his mechanism [29]. Olaleye et al. [30] reported that rutin and
uercetin reduced the blood pressure of animals induced with
igh salt diet. Overstimulation of the renin-angiotensin system
RAS), and by extension ACE, is one means by which high salt
oncentration induces hypertension [31]. Going by the afore-
entioned, it is safe to hypothesize that ACTE could exert its
ypotensive effect by interfering with ACE through one or more
f its constituent flavonoids.
In the present study, ACTE did not adversely affect
erum total cholesterol and markers of tissue injury: crea-
ine kinase CK, aspartate aminotransferase AST and alanine
dices of rats.
AST (U/L) ALP (mg/dL) CHOL (mg/dL)
26.67 ± 0.24 82.50 ± 2.33 18.58 ± 1.3
27.07 ± 0.28 74.58 ± 1.81*** 16.07 ± 1.3**
26.87 ± 0.38 66.00 ± 2.33*** 12.29 ± 1.2***
26.00 ± 0.24** 59.40 ± 2.33*** 19.22 ± 1.3
25.40 ± 0.43*** 68.64 ± 2.76*** 13.23 ± 0.86***
ine kinase; ALT: alanine amino transferase; AST: aspartate amino transferase;
120 O.S. Olayeriju et al. / Food Science and Human Wellness 4 (2015) 115–122
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iig. 2. Effects of ethylacetate extract of Allium cepa tunic (ACTE) on cardiac ac
C) in rats. P value: ***<0.001 compared with the normal control group. ACTE
minotransferase ALT. Serum CK and AST have been used as
ndicators of the stage of myocardial injury [13]. The activities
f these cellular enzymes present in the blood are directly related
o the intactness of the plasma membrane of the cardiac cells.
herefore, the inhibition of the release of these enzymes into
he serum by ACTE could be due to the ability of some of the
avonoids present in the extract to maintain cardiac membrane
ntegrity and restrict the leakage of these enzymes [32]. Con-
ersely, the ability of the ACTE to reduce serum cholesterol in
reated animals portrays good signal for cardioprotection taken
nto consideration the role hyperlipidemia plays in the etiology
nd progression of many cardiovascular diseases [33,34].
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ss of superoxide dismutase (A) and catalase (B), and level of reduced glutathione
lacetate extract of Allium cepa tunic; Ram: ramipril.
Superoxide dismutase (SOD) and catalase are endogenous
ntioxidant enzymes responsible for the dismutation of super-
xide radicals to H2O2 and detoxification of H2O2 to water,
espectively. Coupled with the actions of the master endoge-
ous antioxidant molecule, GSH, these enzymes offer protection
gainst tissue damage [35]. In the present study, we observed
n increase in the activities of cardiac SOD and catalase with
oncomitant decrease in GSH. The observed effect on GSH
s a deviation from the well-established antioxidant activity
f flavonoids [36]. It is however known that in  vivo, some
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f H2O2 production [35,38]. Such prooxidative tendency does
ot necessarily indicate toxicity in its entirety but could be
eneficial and capable of causing overall cytoprotection [35],
ince levels of some antioxidant defenses and biotransformation
nzymes might be elevated due to the mild degree of oxidative
tress ensuing [39]. Oxidative metabolites of flavonoid such as
uercetin are preferably inactivated by the major intracellular
educing agent GSH, to form two non-reactive products [40].
he reduced level of GSH could thus be due to the modulation
f several biological processes by flavonoids [41].
.  Conclusion
The present study demonstrates the hypotensive effect of red
nion (A.  cepa) tunic which is often discarded as wastes. Further
nvestigation is however in progress, in the case of this study, to
scertain the effect of chronic consumption of ACTE and evalu-
te the individual or synergistic contribution(s) of its flavonoids
o the observed hypotensive effect.
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